3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Lung Neoplasms
21
Breast Neoplasms
18
Hematologic Neoplasms
16
Colorectal Neoplasms
12
Prostatic Neoplasms
11
Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pancreatic Neoplasms
9
Hematopoietic and Lymphatic System Neoplasm
9
Anatomic Stage I Breast Cancer AJCC v8
9
Urinary Bladder Neoplasms
6
Ovarian Neoplasms
6
Neoplasm Metastasis
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Multiple Myeloma
5
Leukemia, Myeloid, Acute
5
Head and Neck Carcinoma
5
Breast Carcinoma In Situ
5
Triple Negative Breast Neoplasms
4
Stomach Neoplasms
4
Melanoma
4
Hematopoietic and Lymphoid System Neoplasm
4
Carcinoma, Renal Cell
4
Rectal Neoplasms
3
Myelodysplastic Syndromes
3
Mouth Neoplasms
3
Malignant Solid Neoplasm
3
Lymphoma
3
Head and Neck Neoplasms
3
Interventions
Paclitaxel
24
Hyperthermic Intraperitoneal Chemotherapy
24
Cisplatin
22
Oxaliplatin
17
Carboplatin
17
Fluorouracil
13
Cytoreduction Surgical Procedures
13
Bevacizumab
10
Mitomycin
9
Leucovorin
8
Doxorubicin
8
Docetaxel
6
Gemcitabine
5
130-nm albumin-bound paclitaxel
5
Surgical Procedures, Operative
4
Blood Specimen Collection
4
Albumin-Bound Paclitaxel
4
sodium thiosulfate
3
liposomal doxorubicin
3
catumaxomab
3
Taxes
3
Neoadjuvant Therapy
3
Drug Therapy
3
tremelimumab
2
relacorilant
2
pembrolizumab
2
olaparib
2
nintedanib
2
epothilone B
2
Topotecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Peritoneal Neoplasms
×
Practice Guidelines as Topic
×
Clear all
NCT07001748
2026-05-15
STOPGAP II
Eastern Cooperative Oncology Group
Phase 2/3
Recruiting
148 enrolled